2Brucato A, Buyon JP, Horsfall AC, et al. Foourth international workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB system. Clin Exp Rhemuatol, 1999,17(1):130-136.
3Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med, 1994,120(7) :544-551.
4Thornton CM, Eichenfield LF, Shinall EA, et al. Cutaneous telangiectasia in neonatal lupus erythematosus. J Am Acad Dermatol, 1995,33(1):19-25.
5Furukawa F, Itoh T, Wakita H, et al. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol, 1999, 118(1): 164-170.
6Taylor-Albert E, Reichlin M,Toews WH, et al. Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: case reports, autoantibody analysis and management. Pediatrics, 1997,99(5):733-735.
7Lee LA, Weston WL. Cutaneous lupus erythematosus during the neonatal and childhood periods. Lupus, 1997,6(2): 132-138.
8Sheth AP, Esterly NB, Ratoosh SL, et al. U1RNP positive neonatal lupus erythematosus: association with anti-La antibodies. Br J Dematol, 1995,132(4): 520-526.
9Lee AL, Frank MB, McCubbin VR, et al. Autoantibodies of neonatal lupus erythematosus. J Invest Dermatol, 1994,102(6):963-966.
10Silverman ED, Buyon JP, Laxer RM, et al. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol, 1995,100(3):499-505.
